What You Should Know:
– OncoHost, a company pioneering personalized medicine approaches for better patient outcomes, announced a collaborative research study with Dana-Farber Cancer Institute, a leading cancer treatment and research center.
– The project aims…
Continue Reading
What You Should Know:
– OM1 introduces three new products: OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine and clinical research.
– OM1 is…
Continue Reading
Cardiac digital twins provide a physics and physiology informed framework to deliver personalized medicine. However, high-fidelity multi-scale cardiac models remain a barrier to adoption due to their extensive computational costs. Artificial Intelligence-based methods can…
Continue Reading
What You Should Know:
– Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
– The investment brings Nucleai’s total funding to $60M…
Continue Reading
Anna McCowan, Software Manager at Keysight Technologies AI is impacting every aspect of our lives, and the healthcare industry is no exception. With digital transformation a perennial focus for the sector, AI is increasingly…
Continue Reading
Anthony Loss, Director of Solutions Strategy at ClearScale Having a comprehensive data strategy is paramount in the healthcare sector. Data can be both a blessing and a curse for healthcare organizations, depending on how…
Continue Reading
The Tsukuba team’s innovative CT-based radiomics deep learning model exhibits an 89% accuracy in predicting lymph node metastasis in nonfunctional pancreatic neuroendocrine tumors (NF-PNETs). Validated with external hospital data, the model maintains a remarkable…
Continue Reading
What You Should Know: – Amgen, a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja. – The new initiative will harness the power of an NVIDIA DGX SuperPOD, christened after…
Continue Reading
Britton Burton Sr. Director of TPRM Strategy
Morgan Hague, Manager of IT Risk Management at Meditology Services
Leaps in healthcare technology continue to benefit humankind: from the advent of the X-ray in the 19th century to…
Continue Reading
Lunit SCOPE IO, driven by AI, achieved a groundbreaking success in a phase III trial for NSCLC patients with EGFR or ALK mutations, published in the Journal of Clinical Oncology. This marks a pivotal…
Continue Reading
